Hosted on MSN10mon
Regeneron reports positive data from Phase I/II multiple myeloma trialRegeneron Pharmaceuticals has reported encouraging results from the Phase I/II LINKER-MM1 clinical trial of its investigational bispecific antibody, linvoseltamab, in patients with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback